Introduction of PAMORELIN LA
11.25 MG:

Pamorelin LA 11.25 mg Injection belongs to the class of
'anti-neoplastic agents', primarily used to treat prostate cancer in men,
endometriosis in women and precocious puberty (early puberty) in children.
Prostate cancer is the prostate gland's cancer (a small gland under the bladder
secretes fluid that nourishes and protects sperm) found only in men.
Endometriosis is a disorder in which tissue lining the uterus grows outside the
uterine cavity. Precocious puberty occurs when a child's body changes into that
of an adult or experiences puberty too soon.

Pamorelin LA 11.25 mg Injection contains Triptorelin that belongs
to the class of gonadotropin-releasing hormone (GnRH) agonists. Triptorelin is
a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus
gland in the brain. It works by inhibiting the synthesis of the natural male
hormone, testosterone in men and oestrogen in women. The lowering of
testosterone hormone levels in men helps slows down the growth of cancer cells
in prostate cancer.

Use Pamorelin LA 11.25 mg Injection as prescribed by your doctor.
Your doctor will decide the dosage depending on your medical condition. The
common side effects of Pamorelin LA 11.25 mg Injection include hot flashes,
decreased sexual interest, shrinking of the testicles, breast tenderness or
swelling, dizziness, headache, flu symptoms, nausea, vomiting, diarrhoea, upset
stomach and swelling in legs. These side effects are not familiar to
everyone and vary individually. If you notice any side effects that are not
manageable, please consult your doctor.

Uses of PAMORELIN LA
11.25 MG:

·
Prostate cancer

How to use PAMORELIN LA
11.25 MG:

It will be administered by a
healthcare professional; do not self-administer.